Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells

Nutrition and Cancer

Volumn 36, Issue 1, 2000, Pages 101-111

  Karas, Michael ^a   Amir, Hadar ^a   Fishman, Daniel ^a   Danilenko, Michael ^a   Segal, Shraga ^a   Nahum, Amit ^a   Koifmann, Arie ^a   Giat, Yudit ^a   Levy, Joseph ^a   Sharoni, Yoav ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; HUMAN; HUMAN CELL; PROSTATE CARCINOMA; RISK FACTOR;

LYCOPERSICON ESCULENTUM;

EID: 17144452288     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3601_14     Document Type: Article

References (54)

1. LeRoith, D, Werner, H, Beitner-Johnson, D, and Roberts, CT, Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16, 143-159, 1995.
2. Butler, AA, Blakesley, VA, Tsokos, M, Pouliki, V, Wood, TL, et al.: Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res 58, 3021-3027, 1998.
3. Chan, JM, Stampfer, MJ, Giovannucci, E, Gann, PH, Ma, J, et al.: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563-566, 1998.
4. Hankinson, SE, Willett, WC, Colditz, GA, Hunter, DJ, Michaud, DS, et al.: Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 351, 1393-1396, 1998.
5. Czech, MP: Signal transmission by the insulin-like growth factors. Cell 59, 235-238, 1989.
6. Drop, SL, Schuller, AG, Lindenbergh, KD, Groffen, C, Brinkman, A, et al.: Structural aspects of the IGFBP family. Growth Regul 2, 69-79, 1992.
7. Prager, D. Li, HL, Asa, S, and Melmed, S: Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91, 2181-2185, 1994.
8. Resnifcoff, M, Burgaud, JL, Rotman, HL, Abraham, D, and Baserga, R: Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55, 3739-3741, 1995.
9. Van Poppel, G: Carotenoids and cancer: an update with emphasis on human intervention studies. Eur J Cancer 29A, 1335-1344, 1993.
10. Hennekens, CH, Buring, JE, Manson, JE, Stampfer, M, Rosner, B, et al.: Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149, 1996.
11. Greenberg, ER, Baron, JA, Tosteson, TD, Freeman, DH, Beck, GJ, et al.: Clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 331, 141-147, 1994.
12. Heinonen, OP, Huttunen, JK, Albanes, D, Haapakoski, J, Palmgren, J, et al.: Effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035, 1994.
13. Omenn, GS, Goodman, GE, Thornquist, MD, Balmes, J, Cullen, MR, et al.: Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155, 1996.
14. Zhang, SM, Tang, GW, Russell, RM, Mayzel, KA, Stampfer, MJ, et al.: Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am J Clin Nutr 66, 626-632, 1997.
15. Helzlsouer, KJ, Comstock, GW, and Morris, JS: Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res 49, 6144-6148, 1989.
16. Burney, PG, Comstock, GW, and Morris, JS: Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 49, 895-900, 1989.
17. Goodman, MT, Kolonel, LN, Wilkens, LR, Yoshizawa, CN, Lemarchand, L, et al.: Dietary factors in lung cancer prognosis. Eur J Cancer 28, 495-501, 1992.
18. Giovannucci, E, Ascherio, A, Rimm, EB, Stampfer, MJ, Colditz, GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. JNCI 87, 1767-1776, 1995.
19. VanEenwyk, J, Davis, FG, and Bowen, PE: Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48, 34-38, 1991.
20. Giovannucci, E: Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. JNCI 91, 317-331, 1999.
21. Wang, C-J, and Lin, J-K: Inhibitory effects of carotenoids and retinoids on the in vitro growth of rat C-6 glioma cells. Proc Natl Sci Counc Repub China B 13, 176-183, 1989.
22. 3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer 33, 105-112, 1999.
23. Wang, CJ, Chou, MY, and Lin, JK: Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids. Cancer Lett 48, 135-142, 1989.
24. Nagasawa, H, Mitamura, T, Sakamoto, S, and Yamamoto, K: Effect of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res 15, 1173-1178, 1995.
25. Kobayashi, T, Itjima, K, Mitamura, T, Torilzuka, K, Cyong, J, et al.: Effect of lycopene, a carotenoid, on intrathymic T cell differentiation and peripheral CD4/CD8 ratio in a high mammary tumor strain of SHN retired mice. Anticancer Drugs 7, 195-198, 1996.
26. Kim, DJ, Takasuka, N, Kim, JM, Sekine, K., Ota, T, et al.: Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 120, 15-22, 1997.
27. Narisawa, T, Fukaura, Y, Hasebe, M, Ito, M, Aizawa, R, et al.: Inhibitory effects of natural carotenoids, α-carotene, β-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107, 137-142, 1996.
28. Sharoni, Y, Giron, E, Rise, M, and Levy, J: Effects of lycopene enriched tomato oleoresin on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Cancer Detect Prev 21, 118-123, 1997.
29. Levy, J, Bosin, E, Feldman, B, Giat, Y, Miinster, A, et al.: Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 24, 257-267, 1995.
30. Sharoni, Y, and Levy, J: Anticarcinogenic properties of lycopene. In Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention, JT Kumpulainen and JK Salonen (eds). Cambridge, UK: Roy Soc Chem, 1996, pp 378-385.
31. Stahl, W, Sundquist, AR, Hanusch, M, Schwarz, W, and Sies, H: Separation of β-carotene and lycopene geometrical isomers in biological samples. Clin Chem 39, 810-814, 1993.
32. Karas, M, Danilenko, M, Fishman, D, LeRoith, D, Levy, J, et al.: Membrane associated IGFBP-3 inhibits insulin-like growth factor-I (IGF-I)-induced IGF-I receptor signaling in Ishikawa endometrial cancer cells. J Biol Chem 272, 16514-16520, 1997.
33. Kleinman, D, Karas, M, Roberts, CT, Jr, LeRoith, D, Phillip, M, et al.: Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 136, 2531-2537, 1995.
34. Munson, PJ, and Rodbard, D: A versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107, 220-239, 1980.
35. Vermes, I, Haanen, C, Steffens Nakken, H, and Reutelingsperger, C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184, 39-51, 1995.
36. Tamir, A, and Isakov, N: Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J Immunol 152, 3391-3399, 1994.
37. Sutherland, RL, Watts, CK, and Musgrove, EA: Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J Steroid Biochem Mol Biol 47, 99-106, 1993.
38. Lin, HB, Falchetto, R, Mosca, PJ, Shabanowitz, J, Hunt, DF, et al.: Mimosine targets serine hydroxymethyltransferase. J Biol Chem 271, 2548-2556, 1996.
39. Gooch, JL, Lee, AV, and Yee, D: Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res 58, 4199-4205, 1998.
40. Chu, G: Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269, 787-790, 1994.
41. Martin, SJ, Reutelingsperger, CP, McGahon, AJ, Rader, JA, van Schie, RC, et al.: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182, 1545-1556, 1995.
42. 1 arrest in human MCF-7 breast cancer cells. Br J Cancer 77, 186-191, 1998.
43. Angel, P, and Karin, M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072, 129-157, 1991.
44. Karas, M, Kleinman, D, Danilenko, M, Roberts, CR, Jr, LeRoith, D, et al.: Components of the IGF system mediate the opposing effects of tamoxifen on endometrial and breast cancer cell growth. Prog Growth Factor Res 6, 513-520, 1995.
45. Gerster, H: The potential role of lycopene for human health. J Am Coll Nutr 16, 109-126, 1997.
46. Fontana, JA, Burrowsmezu, A, Clemmons, DR, and Leroith, D: Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 128, 1115-1122, 1991.
47. Kleinman, D, Karas, M, Danilenko, M, Arbeli, A, Roberts, CT, Jr, et al.: Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased IGF-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology 137, 1089-1095, 1996.
48. Muto, Y, Fujii, J, Shidoji, Y, Moriwaki, H, Kawaguchi, T, et al.: Growth retardation in human cervical dysplasia-derived cell lines by β-carotene through down-regulation of epidermal growth factor receptor. Am J Clin Nutr 62, 1535S-1540S, 1995.
49. Sun, Y, and Oberley, LW: Redox regulation of transcriptional activators. Free Radic Biol Med 21, 335-348, 1996.
50. Stahl, W, Junghans, A, deBoer, B, Driomina, ES, Briviba, K, et al.: Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 427, 305-308, 1998.
51. Pinkus, R, Weiner, LM, and Daniel, V: Role of oxidants and antioxidants in the induction of AP-1, NF-KB, and glutathione S-transferase gene expression. J Biol Chem 271, 13422-13429, 1996.
52. Singh, S, and Aggarwal, BB: Activation of transcription factor NF-KB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270, 24995-5000, 1995.
53. Werner, H, and LeRoith, D: The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68, 183-223, 1996.
54. Murakoshi, M, Takayasu, J, Kimura, O, Kohmura, E, Nishino, H, et al.: Inhibitory effects of α-carotene on proliferation of the human neuroblastoma cell line GOTO. JNCI 81, 1649-1652, 1989.